PP2A targeting: balancing anticancer potential and neurological risk. [PDF]
Chigriai M +5 more
europepmc +1 more source
Resistance to third-generation EGFR TKIs - what can be expected from the fourth-generation? [PDF]
Dempke WCM +3 more
europepmc +1 more source
KRAS signaling networks, mutational heterogeneity, and emerging therapeutic strategies for cancer treatment. [PDF]
Jin S +5 more
europepmc +1 more source
Cobimetinib impairs tumor survival and immune escape by altering my-CAFs in BRAFV600E-mutated anaplastic thyroid carcinoma. [PDF]
Udinotti M +9 more
europepmc +1 more source
MEK interactions tune RAF kinase sensitivity to conformation-selective inhibition. [PDF]
Stoddard EG +8 more
europepmc +1 more source
Disarming cancer resistance: FAK as a therapeutic target. [PDF]
Haanen TJ, Schlaepfer DD.
europepmc +1 more source
RUVBL1 and CRAF promote periodontal ligament stem cell osteogenic differentiation via the MEK/ERK signaling cascade. [PDF]
Zhang XY, Hao P, Qi MY, Guo H.
europepmc +1 more source
Guard cell signal transduction mechanisms controlling stomatal movements by light, abscisic acid, CO2, VPD and heat. [PDF]
Schroeder JI +3 more
europepmc +1 more source
Raf Kinase Inhibitory Protein Suppresses a Metastasis Signalling Cascade Involving LIN28 and Let‐7 [PDF]
Raf kinase inhibitory protein (RKIP) negatively regulates the MAP kinase (MAPK), G protein-coupled receptor kinase-2, and NF-κB signalling cascades. RKIP has been implicated as a metastasis suppressor for prostate cancer, but the mechanism is not known ...
Marsha Rosner +2 more
exaly +2 more sources

